Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis

Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
Michael Rubin, Sanjay N Rao

Abstract

We assessed the efficacy of topical cyclosporin 0.05% ophthalmic emulsion versus tobramycin 0.3%/dexamethasone 0.1% in patients with posterior blepharitis. Posterior blepharitis improved significantly from the initial study visit with both cyclosporin treatment and tobramycin/dexamethasone. Cyclosporin provided greater improvements in Schirmer's scores (P < 0.001) and tear break-up time (P = 0.018) than tobramycin/dexamethasone after 12 weeks of treatment. Eyelid health also improved in both groups, but the mean improvement in meibomian gland secretion quality was significantly greater with cyclosporin than with tobramycin/dexamethasone (P = 0.015). Moreover, a higher percentage of patients in the cyclosporin treatment group had improvements in symptoms of blurred vision, burning, and itching and more cyclosporin-treated patients experienced resolution of lid telangiectasia. The findings in this prospective study suggest that posterior blepharitis can be more effectively treated with cyclosporin than with tobramycin/dexamethasone. These findings should be further evaluated in large-scale, controlled, clinical trials.

References

Mar 28, 1975·Science·A J Wicken, K W Knox
Dec 1, 1991·Infection and Immunity·S BhakdiW Fischer
Dec 1, 1990·Ophthalmology·D SealP Wright
Sep 1, 1983·The Medical Clinics of North America·D Pavan-Langston
Aug 1, 1993·The British Journal of Ophthalmology·I CarrerasD L Easty
May 12, 1998·Clinical Immunology and Immunopathology·M T MagoneS M Whitcup
Jul 23, 1999·Annals of the New York Academy of Sciences·L LanzaF Indiveri
Dec 11, 1999·Chemical Immunology·G LiuS J Ono
Sep 29, 2000·Cornea·J P McCulley, W E Shine
Jan 6, 2001·Current Opinion in Ophthalmology·M C Carnahan, D A Goldstein
Jun 20, 2003·Current Eye Research·Mary MarquartJames Hill
Jul 23, 2003·European Journal of Ophthalmology·A G Koçak-AltintasS Duman
Mar 10, 2004·Archives of Ophthalmology·Mark C GilliesAlex B L Hunyor
Apr 8, 2004·Clinical & Experimental Ophthalmology·Helen M Garrott, Mark J Walland
Oct 14, 2004·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·T Kaercher, H Brewitt
Nov 10, 2004·Archives of Ophthalmology·William D Mathers, Dongseok Choi
Nov 27, 2004·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Eckart Bertelmann, Uwe Pleyer

❮ Previous
Next ❯

Citations

Sep 1, 2007·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C Auw-Haedrich, T Reinhard
Jun 6, 2009·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C Auw-Hädrich, T Reinhard
Jul 27, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ilknur Akyol-SalmanOrhan Baykal
Jul 15, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ilknur Akyol-SalmanOrhan Baykal
Apr 16, 2013·The British Journal of Ophthalmology·Reiko AritaShiro Amano
Jan 5, 2014·PloS One·Chun-Chi ChiangFung-Chang Sung
Oct 7, 2014·The Ocular Surface·Stephen C PflugfelderVictor L Perez
Oct 10, 2007·Expert Opinion on Investigational Drugs·Eddy AngladeUlrich Grau
Feb 25, 2014·American Journal of Ophthalmology·Kyung Eun HanKyoung Yul Seo
Mar 31, 2011·Biotechnology Advances·Shrikant A SurvaseRekha S Singhal
Feb 1, 2011·Ophthalmology·Arie Y NemetIgor Kaiserman
Dec 31, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Yesim AltayHulya Bolu
May 9, 2009·Survey of Ophthalmology·Eric Donnenfeld, Stephen C Pflugfelder
Jun 19, 2007·Survey of Ophthalmology·Gary N Foulks
Nov 19, 2010·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Dominick L Opitz, Keith F Tyler
May 8, 2013·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Markus ReinholzJürgen Schauber
Mar 22, 2016·Journal français d'ophtalmologie·O LevyN Bouheraoua
Apr 16, 2016·Drug Discovery Today·Priyanka Agarwal, Ilva D Rupenthal
Aug 26, 2010·Ocular Immunology and Inflammation·Canan Asli UtineEsen K Akpek
Jun 18, 2016·Acta Ophthalmologica·Hon Shing OngMorten Praestegaard
Nov 7, 2016·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·C Auw-Hädrich, T Reinhard
Nov 22, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·M SchallerM Steinhoff
Nov 22, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·M SchallerM Steinhoff
Jan 30, 2016·The British Journal of Ophthalmology·Morgane StraubCatherine Creuzot-Garcher
Feb 9, 2017·The Cochrane Database of Systematic Reviews·Michael O'GallagherAnnegret Dahlmann-Noor
Aug 21, 2010·Eye & Contact Lens·Gary N Foulks, Douglas Borchman
Jan 2, 2018·The Open Ophthalmology Journal·Kannan Sridharan, Gowri Sivaramakrishnan
Oct 25, 2006·International Ophthalmology Clinics·Gary N Foulks
Sep 18, 2010·Cornea·Caroline A BlackieEdward J Holland
May 18, 2012·The Cochrane Database of Systematic Reviews·Kristina LindsleyEsen K Akpek
Jun 10, 2015·Current Opinion in Ophthalmology·Katherine Duncan, Bennie H Jeng
Jun 26, 2012·Journal of Midwifery & Women's Health·Dianne Fuller, Suzanne Martin
Aug 26, 2009·Clinical & Experimental Ophthalmology·Mustafa GuzeyOmer Bozkurt
Nov 17, 2015·Current Opinion in Ophthalmology·Christine SutuNatalie A Afshari
Jan 10, 2018·Molecular Pharmaceutics·Maria A GrimaudoSara Nicoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.